- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global Biosimilar Testing and Development Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biosimilar Testing and Development Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilar Testing and Development Services market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Biosimilar Testing and Development Services market has been segmented into Effector Binding, ELISA, Kinetic Binding Assays, ADCC & CDC Cell-Based Assays, etc.
Breakdown by Application, Biosimilar Testing and Development Services has been segmented into PK assay, Tiered Immunogenicity testing, NAb assays, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilar Testing and Development Services market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilar Testing and Development Services markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilar Testing and Development Services market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Biosimilar Testing and Development Services Market Share Analysis
Biosimilar Testing and Development Services competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Biosimilar Testing and Development Services revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilar Testing and Development Services revenue and market share for each player covered in this report.
The major players covered in Biosimilar Testing and Development Services are: Eurofins Scientific, Medistri, Pharmaceutical Product Development, SGS, Intertek Group, Charles River Laboratories, Sigma-Aldrich, Source BioScience, Exova, Pace Analytical Services, etc. Among other players domestic and global, Biosimilar Testing and Development Services market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Eurofins Scientific
Medistri
Pharmaceutical Product Development
SGS
Intertek Group
Charles River Laboratories
Sigma-Aldrich
Source BioScience
Exova
Pace Analytical Services
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Market segment by Application, can be divided into
PK assay
Tiered Immunogenicity testing
NAb assays
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Biosimilar Testing and Development Services
1.2 Classification of Biosimilar Testing and Development Services by Type
1.2.1 Overview: Global Biosimilar Testing and Development Services Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Biosimilar Testing and Development Services Revenue Market Share by Type in 2019
1.2.3 Effector Binding
1.2.4 ELISA
1.2.5 Kinetic Binding Assays
1.2.6 ADCC & CDC Cell-Based Assays
1.3 Global Biosimilar Testing and Development Services Market by Application
1.3.1 Overview: Global Biosimilar Testing and Development Services Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Global Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
1.5 Global Biosimilar Testing and Development Services Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Biosimilar Testing and Development Services Market Size by Regions (2015-2020)
1.7 Global Biosimilar Testing and Development Services Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.7.2 Europe Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.7.3 Asia Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.7.4 South America Biosimilar Testing and Development Services Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Biosimilar Testing and Development Services Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eurofins Scientific SWOT Analysis
2.1.4 Eurofins Scientific Product and Services
2.1.5 Eurofins Scientific Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.2 Medistri
2.2.1 Medistri Details
2.2.2 Medistri Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Medistri SWOT Analysis
2.2.4 Medistri Product and Services
2.2.5 Medistri Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pharmaceutical Product Development
2.3.1 Pharmaceutical Product Development Details
2.3.2 Pharmaceutical Product Development Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pharmaceutical Product Development SWOT Analysis
2.3.4 Pharmaceutical Product Development Product and Services
2.3.5 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.4 SGS
2.4.1 SGS Details
2.4.2 SGS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 SGS SWOT Analysis
2.4.4 SGS Product and Services
2.4.5 SGS Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.5 Intertek Group
2.5.1 Intertek Group Details
2.5.2 Intertek Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Intertek Group SWOT Analysis
2.5.4 Intertek Group Product and Services
2.5.5 Intertek Group Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Charles River Laboratories SWOT Analysis
2.6.4 Charles River Laboratories Product and Services
2.6.5 Charles River Laboratories Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sigma-Aldrich
2.7.1 Sigma-Aldrich Details
2.7.2 Sigma-Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sigma-Aldrich SWOT Analysis
2.7.4 Sigma-Aldrich Product and Services
2.7.5 Sigma-Aldrich Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.8 Source BioScience
2.8.1 Source BioScience Details
2.8.2 Source BioScience Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Source BioScience SWOT Analysis
2.8.4 Source BioScience Product and Services
2.8.5 Source BioScience Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.9 Exova
2.9.1 Exova Details
2.9.2 Exova Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Exova SWOT Analysis
2.9.4 Exova Product and Services
2.9.5 Exova Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pace Analytical Services
2.10.1 Pace Analytical Services Details
2.10.2 Pace Analytical Services Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pace Analytical Services SWOT Analysis
2.10.4 Pace Analytical Services Product and Services
2.10.5 Pace Analytical Services Biosimilar Testing and Development Services Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biosimilar Testing and Development Services Market Size by Players (2015-2020)
3.2 Japan Biosimilar Testing and Development Services Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Biosimilar Testing and Development Services Players Market Share
3.3.2 Top 10 Biosimilar Testing and Development Services Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Biosimilar Testing and Development Services Market Size by Countries (2015-2020)
4.2 North America Biosimilar Testing and Development Services Market Size and Forecast by Countries (2015-2026)
4.3 United States Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
4.4 Canada Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
4.5 Mexico Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Biosimilar Testing and Development Services Market Size by Countries (2015-2020)
5.2 Europe Biosimilar Testing and Development Services Market Size and Forecast by Countries (2015-2026)
5.3 Germany Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
5.4 France Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
5.5 UK Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
5.6 Russia Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
5.7 Italy Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Regions (2015-2020)
6.2 Asia-Pacific Biosimilar Testing and Development Services Market Size and Forecast by Regions (2015-2026)
6.3 China Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
6.4 Japan Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
6.5 Korea Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
6.6 India Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
6.7 Southeast Asia Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Biosimilar Testing and Development Services Market Size by Countries (2015-2020)
7.2 South America Biosimilar Testing and Development Services Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
7.4 Argentina Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Biosimilar Testing and Development Services Revenue by Regions (2015-2020)
8.2 Middle East & Africa Biosimilar Testing and Development Services Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
8.4 UAE Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
8.5 Egypt Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
8.6 South Africa Biosimilar Testing and Development Services Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Biosimilar Testing and Development Services Market Size and Forecast by Type (2015-2025)
9.1.1 Global Biosimilar Testing and Development Services Market Size by Type (2015-2020)
9.1.2 Global Biosimilar Testing and Development Services Market Size Forecast by Type (2020-2025)
9.2 Japan Biosimilar Testing and Development Services Market Size and Forecast by Type (2015-2025)
9.2.1 Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020)
9.2.2 Japan Biosimilar Testing and Development Services Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Biosimilar Testing and Development Services Market Size and Forecast by Application (2015-2025)
10.1.1 Global Biosimilar Testing and Development Services Market Size by Application (2015-2020)
10.1.2 Global Biosimilar Testing and Development Services Market Size Forecast by Application (2020-2025)
10.2 Japan Biosimilar Testing and Development Services Market Size and Forecast by Application (2015-2025)
10.2.1 Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020)
10.2.2 Japan Biosimilar Testing and Development Services Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Biosimilar Testing and Development Services Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Biosimilar Testing and Development Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Testing and Development Services Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Biosimilar Testing and Development Services Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Biosimilar Testing and Development Services Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Biosimilar Testing and Development Services Revenue Share by Regions (2015-2020)
Table 7. Global Biosimilar Testing and Development Services Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Biosimilar Testing and Development Services Revenue Market Share by Regions (2020-2025)
Table 9. Eurofins Scientific Corporate Information, Location and Competitors
Table 10. Eurofins Scientific Major Business
Table 11. Eurofins Scientific Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 12. Eurofins Scientific SWOT Analysis
Table 13. Eurofins Scientific Biosimilar Testing and Development Services Product and Solutions
Table 14. Eurofins Scientific Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Medistri Corporate Information, Location and Competitors
Table 16. Medistri Major Business
Table 17. Medistri Biosimilar Testing and Development Services Total Revenue (USD Million) (2018-2019)
Table 18. Medistri SWOT Analysis
Table 19. Medistri Biosimilar Testing and Development Services Product and Solutions
Table 20. Medistri Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Pharmaceutical Product Development Corporate Information, Location and Competitors
Table 22. Pharmaceutical Product Development Major Business
Table 23. Pharmaceutical Product Development Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 24. Pharmaceutical Product Development SWOT Analysis
Table 25. Pharmaceutical Product Development Biosimilar Testing and Development Services Product and Solutions
Table 26. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. SGS Corporate Information, Location and Competitors
Table 28. SGS Major Business
Table 29. SGS Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 30. SGS SWOT Analysis
Table 31. SGS Biosimilar Testing and Development Services Product and Solutions
Table 32. SGS Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Intertek Group Corporate Information, Location and Competitors
Table 34. Intertek Group Major Business
Table 35. Intertek Group Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 36. Intertek Group SWOT Analysis
Table 37. Intertek Group Biosimilar Testing and Development Services Product and Solutions
Table 38. Intertek Group Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Charles River Laboratories Corporate Information, Location and Competitors
Table 40. Charles River Laboratories Major Business
Table 41. Charles River Laboratories Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 42. Charles River Laboratories SWOT Analysis
Table 43. Charles River Laboratories Biosimilar Testing and Development Services Product and Solutions
Table 44. Charles River Laboratories Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Sigma-Aldrich Corporate Information, Location and Competitors
Table 46. Sigma-Aldrich Major Business
Table 47. Sigma-Aldrich Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 48. Sigma-Aldrich SWOT Analysis
Table 49. Sigma-Aldrich Biosimilar Testing and Development Services Product and Solutions
Table 50. Sigma-Aldrich Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Source BioScience Corporate Information, Location and Competitors
Table 52. Source BioScience Major Business
Table 53. Source BioScience Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 54. Source BioScience SWOT Analysis
Table 55. Source BioScience Biosimilar Testing and Development Services Product and Solutions
Table 56. Source BioScience Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. Exova Corporate Information, Location and Competitors
Table 58. Exova Major Business
Table 59. Exova Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 60. Exova SWOT Analysis
Table 61. Exova Biosimilar Testing and Development Services Product and Solutions
Table 62. Exova Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Pace Analytical Services Corporate Information, Location and Competitors
Table 64. Pace Analytical Services Major Business
Table 65. Pace Analytical Services Biosimilar Testing and Development Services Total Revenue (USD Million) (2017-2018)
Table 66. Pace Analytical Services SWOT Analysis
Table 67. Pace Analytical Services Biosimilar Testing and Development Services Product and Solutions
Table 68. Pace Analytical Services Biosimilar Testing and Development Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Global Biosimilar Testing and Development Services Revenue (USD Million) by Players (2015-2020)
Table 70. Global Biosimilar Testing and Development Services Revenue Share by Players (2015-2020)
Table 71. Key Players Biosimilar Testing and Development Services Revenue (USD Million) in Japan (2015-2020)
Table 72. Key Players Biosimilar Testing and Development Services Revenue Share in Japan (2015-2020)
Table 73. North America Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2015-2020)
Table 74. North America Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 75. North America Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2020-2026)
Table 76. North America Biosimilar Testing and Development Services Revenue Market Share by Countries (2020-2026)
Table 77. Europe Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2015-2020)
Table 78. Europe Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 79. Europe Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2020-2026)
Table 80. Europe Biosimilar Testing and Development Services Revenue Market Share by Countries (2020-2026)
Table 81. Asia-Pacific Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2015-2020)
Table 82. Asia-Pacific Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 83. Asia-Pacific Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2020-2026)
Table 84. Asia-Pacific Biosimilar Testing and Development Services Revenue Market Share by Countries (2020-2026)
Table 85. South America Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2015-2020)
Table 86. South America Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 87. South America Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2020-2026)
Table 88. South America Biosimilar Testing and Development Services Revenue Market Share by Countries (2020-2026)
Table 89. Middle East & Africa Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2015-2020)
Table 90. Middle East & Africa Biosimilar Testing and Development Services Revenue Market Share by Countries (2015-2020)
Table 91. Middle East & Africa Biosimilar Testing and Development Services Revenue (USD Million) by Countries (2020-2026)
Table 92. Middle East & Africa Biosimilar Testing and Development Services Revenue Market Share by Countries (2020-2026)
Table 93. Global Biosimilar Testing and Development Services Revenue (USD Million) by Type (2015-2020)
Table 94. Global Biosimilar Testing and Development Services Revenue Share by Type (2015-2020)
Table 95. Global Biosimilar Testing and Development Services Revenue Forecast by Type (2020-2025)
Table 96. Global Biosimilar Testing and Development Services Market Share Forecast by Type (2020-2025)
Table 97. Japan Biosimilar Testing and Development Services Revenue (USD Million) by Type (2015-2020)
Table 98. Japan Biosimilar Testing and Development Services Revenue Share by Type (2015-2020)
Table 99. Japan Biosimilar Testing and Development Services Revenue Forecast by Type (2020-2025)
Table 100. Japan Biosimilar Testing and Development Services Market Share Forecast by Type (2020-2025)
Table 101. Global Biosimilar Testing and Development Services Revenue (USD Million) by Application (2015-2020)
Table 102. Global Biosimilar Testing and Development Services Revenue Share by Application (2015-2020)
Table 103. Global Biosimilar Testing and Development Services Revenue Forecast by Application (2020-2025)
Table 104. Global Biosimilar Testing and Development Services Market Share Forecast by Application (2020-2025)
Table 105. Japan Biosimilar Testing and Development Services Revenue (USD Million) by Application (2015-2020)
Table 106. Japan Biosimilar Testing and Development Services Revenue Share by Application (2015-2020)
Table 107. Japan Biosimilar Testing and Development Services Revenue Forecast by Application (2020-2025)
Table 108. Japan Biosimilar Testing and Development Services Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Biosimilar Testing and Development Services Picture
Figure 2. Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Biosimilar Testing and Development Services Revenue Market Share by Type in 2019
Figure 4. Effector Binding Picture
Figure 5. ELISA Picture
Figure 6. Kinetic Binding Assays Picture
Figure 7. ADCC & CDC Cell-Based Assays Picture
Figure 8. Biosimilar Testing and Development Services Revenue Market Share by Application in 2019
Figure 9. PK assay Picture
Figure 10. Tiered Immunogenicity testing Picture
Figure 11. NAb assays Picture
Figure 12. Global Biosimilar Testing and Development Services Revenue and Growth Rate (2015-2025) (USD Million)
Figure 13. Global Biosimilar Testing and Development Services Market Size Share by Regions (2015-2025)
Figure 14. Global Biosimilar Testing and Development Services Market Size Share by Regions in 2019
Figure 15. Global Biosimilar Testing and Development Services Revenue Market Share by Regions (2020-2025)
Figure 16. North America Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. Europe Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. South America Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Middle East & Africa Biosimilar Testing and Development Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Global Biosimilar Testing and Development Services Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Biosimilar Testing and Development Services Revenue Market Share in 2019
Figure 23. Top 10 Players Biosimilar Testing and Development Services Revenue Market Share in Global Market in 2019
Figure 24. Global Biosimilar Testing and Development Services Market Size (USD Million) by Type (2015-2025)
Figure 25. Global Biosimilar Testing and Development Services Market Size Share by Application (2015-2025)
Figure 26. North America Biosimilar Testing and Development Services Market Size Share by Countries (2015-2025)
Figure 27. North America Biosimilar Testing and Development Services Market Size Share by Countries in 2019
Figure 28. United States Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 29. Canada Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Mexico Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 31. Europe Biosimilar Testing and Development Services Market Size Share by Countries (2015-2025)
Figure 32. Europe Biosimilar Testing and Development Services Market Size Share by Countries in 2019
Figure 33. Germany Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 34. France Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Russia Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Italy Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Spain Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 38. UK Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 39. Asia Biosimilar Testing and Development Services Market Size Share by Countries (2015-2025)
Figure 40. Asia Biosimilar Testing and Development Services Market Size Share by Countries in 2019
Figure 41. China Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Japan Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Korea Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 44. India Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 45. Southeast Asia Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 46. South America Biosimilar Testing and Development Services Market Size Share by Countries (2015-2025)
Figure 47. South America Biosimilar Testing and Development Services Market Size Share by Countries in 2019
Figure 48. Brazil Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 49. Argentina Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 50. Middle East & Africa Biosimilar Testing and Development Services Market Size Share by Countries (2015-2025)
Figure 51. Middle East & Africa Biosimilar Testing and Development Services Market Size Share by Countries in 2019
Figure 52. Saudi Arabia Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 53. UAE Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 54. Egypt Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 55. South Africa Biosimilar Testing and Development Services Market Size (USD Million) and Forecast (2015-2025)
Figure 56. Global Biosimilar Testing and Development Services Revenue Share by Type (2015-2020)
Figure 57. Japan Biosimilar Testing and Development Services Revenue Share by Type (2015-2020)
Figure 58. Global Biosimilar Testing and Development Services Revenue Share by Application (2015-2020)
Figure 59. Japan Biosimilar Testing and Development Services Revenue Share by Application (2015-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
